Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Asset Writedowns and Impairment (2023 - 2025)

Historic Asset Writedowns and Impairment for Guardian Pharmacy Services (GRDN) over the last 3 years, with Q3 2025 value amounting to $1.2 million.

  • Guardian Pharmacy Services' Asset Writedowns and Impairment rose 894.31% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.2 million, marking a year-over-year decrease of 647.87%. This contributed to the annual value of $6.4 million for FY2024, which is 2564.1% up from last year.
  • According to the latest figures from Q3 2025, Guardian Pharmacy Services' Asset Writedowns and Impairment is $1.2 million, which was up 894.31% from $1.0 million recorded in Q2 2025.
  • Over the past 5 years, Guardian Pharmacy Services' Asset Writedowns and Impairment peaked at $2.1 million during Q4 2024, and registered a low of $896000.0 during Q1 2025.
  • For the 3-year period, Guardian Pharmacy Services' Asset Writedowns and Impairment averaged around $1.4 million, with its median value being $1.3 million (2023).
  • Per our database at Business Quant, Guardian Pharmacy Services' Asset Writedowns and Impairment surged by 5627.29% in 2024 and then plummeted by 4200.23% in 2025.
  • Over the past 3 years, Guardian Pharmacy Services' Asset Writedowns and Impairment (Quarter) stood at $1.4 million in 2023, then surged by 56.27% to $2.1 million in 2024, then tumbled by 43.38% to $1.2 million in 2025.
  • Its Asset Writedowns and Impairment stands at $1.2 million for Q3 2025, versus $1.0 million for Q2 2025 and $896000.0 for Q1 2025.